Order Article Reprints

Meng X, Zhu X, Ji J, Zhong H, Li X, Zhao H, Xie G, Wang K, Shu H, Wang X. Erdafitinib Inhibits Tumorigenesis of Human Lung Adenocarcinoma A549 by Inducing S-Phase Cell-Cycle Arrest as a CDK2 Inhibitor. Molecules. 2022; 27(19):6733. https://doi.org/10.3390/molecules27196733

Meng, Xinmin, Xue Zhu, Jiali Ji, Hongqin Zhong, Xiyue Li, Hongqing Zhao, Guijuan Xie, Ke Wang, Hong Shu, and Xun Wang. 2022. "Erdafitinib Inhibits Tumorigenesis of Human Lung Adenocarcinoma A549 by Inducing S-Phase Cell-Cycle Arrest as a CDK2 Inhibitor" Molecules 27, no. 19: 6733. https://doi.org/10.3390/molecules27196733

Meng, X., Zhu, X., Ji, J., Zhong, H., Li, X., Zhao, H., Xie, G., Wang, K., Shu, H., & Wang, X. (2022). Erdafitinib Inhibits Tumorigenesis of Human Lung Adenocarcinoma A549 by Inducing S-Phase Cell-Cycle Arrest as a CDK2 Inhibitor. Molecules, 27(19), 6733. https://doi.org/10.3390/molecules27196733